Abstract

(Abstracted from Am J Obstet Gynecol 2022;226:562.e1–562.e8) Recent developments in available techniques for prenatal genetic analysis have significantly changed genetic screening and diagnosis; these include chromosomal microarray analysis (CMA) and cell-free DNA (cfDNA) screening. However, both tests have benefits and drawbacks.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call